Factset Research Systems Inc (FDS) Financial Statements

FactSet's financial health presents a mixed but generally favourable picture for a value investor focused on quality. The company exhibits high profitability, with a 25.4% profit margin and a 32.2% operating margin, which are strong indicators of pricing power and cost control. Free cash flow generation is robust, with an 8.5% FCF yield, comfortably exceeding the framework's >10-15% FCF margin threshold when considered relative to its market cap. The balance sheet is healthy, with a Debt/Equity ratio of 0.71, which is below the cautionary level of 1.0x Debt/EBITDA implied by the framework, indicating a conservative capital structure. Return on Invested Capital (ROIC) is not provided, but the 27.4% ROE far exceeds the 15-20% benchmark for high ROIC, suggesting efficient use of shareholder equity. The primary area of concern is growth. Revenue growth of 6.8% YoY is consistent but falls short of the double-digit, sustainable growth target in the Quality Indicators. This modest growth trajectory, coupled with a P/E of 12.1, suggests the market views FactSet as a stable, cash-generative business rather than a high-growth entity. There are no immediate signs of margin compression or balance sheet deterioration, indicating stable financial quality. Analysis based on data as of 2024-05-15.